Association of low ficolin-lectin pathway parameters with Cardiac Syndrome X

Horváth, Zsófia and Csuka, Dorottya and Vargova, Katarina and Lee, S. and Varga, Lilian and Prohászka, Zoltán and Kiss, Róbert Gábor (2016) Association of low ficolin-lectin pathway parameters with Cardiac Syndrome X. Scandinavian Journal of Immunology, 84 (3). pp. 174-181. ISSN 0300-9475, ESSN: 1365-3083

Preview

Text Horvath_Ficolins_cardiac_syndrome_X_2016_Scandinavian_Journal_of_Immunology_PMID27312152_u.pdf Download (223kB) | Preview

Abstract

In patients with typical angina pectoris, inducable myocardial ischaemia and macroscopically normal coronaries (Cardiac Syndrome X, CSX) significantly elevated plasma level of terminal complement complex (TCC), the common end-product of complement activation, has been observed without subsequent activation of the classical or the alternative pathways. Therefore, our aim was to clarify the role of the ficolin-lectin pathway in CSX. Eighteen CSX patients, 37 stable angina patients with significant coronary stenosis (CHD) and 54 healthy volunteers (HC) were enrolled. Serum levels of ficolin-2, ficolin-3, ficolin-3/MASP-2 complex and ficolin-3 mediated TCC deposition (FCN3-TCC) were determined. Plasma level of TCC was significantly higher in CSX than in HC or in CHD groups (5.45 vs. 1.30 vs. 2.04AU/ml, p<0.001). Serum levels of ficolin-2 and ficolin-3 were significantly lower in CSX compared to HC or to CHD groups (3.60 vs. 5.80 or 5.20mug/ml, p<0.05; 17.80 vs. 24.10 or 26.80mug/ml, p<0.05). The ficolin-3/MASP-2 complex was significantly lower in CSX group compared to HC (92.90 vs. 144.90AU/ml, p=0.006). FCN3-TCC deposition was significantly lower in the CSX group compared to HC and to CHD (67.8% vs.143.3% or 159.7%, p<0.05). In the CSX group, significant correlation was found between TCC and FCN3-TCC level (r=0.507, p=0.032) and ficolin-3/MASP-2 complex level and FCN3-TCC deposition (r=0.651, p=0.003). In conclusion, in patients with typical angina and myocardial ischemia despite macroscopically normal coronary arteries, low levels of several lectin-pathway parameters were observed, indicating complement activation and consumption. Complement activation through the ficolin-lectin pathway might play a role in the complex pathomechanism of CSX. This article is protected by copyright. All rights reserved.

Actions (login required)

Edit Item